FIB‑4 index and serum α‑fetoprotein are useful predictors of hepatocellular carcinoma occurrence in hepatitis B patients with nucleos(t)ide analogs therapy

Current antiviral therapies cannot achieve eradication of hepatitis B virus (HBV) and can reduce but not eliminate the risk of hepatocellular carcinoma (HCC) in patients with chronic HBV infection. The present study aimed to identify the risk factors for HCC development by analyzing nucleoside analo...

Descripción completa

Detalles Bibliográficos
Autores principales: Kuwano, Akifumi, Miyazaki, Masayuki, Yada, Masayoshi, Tanaka, Kosuke, Koga, Yuta, Masumoto, Akihide, Motomura, Kenta
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2023
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443030/
https://www.ncbi.nlm.nih.gov/pubmed/37614433
http://dx.doi.org/10.3892/etm.2023.12140

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10443030/
https://www.ncbi.nlm.nih.gov/pubmed/37614433
http://dx.doi.org/10.3892/etm.2023.12140

Ejemplares similares